Publication - 2012Possible contribution of GSTP1 and other xenobiotic metabolizing genes to vitiligo susceptibility

Publication

Possible contribution of GSTP1 and other xenobiotic metabolizing genes to vitiligo susceptibility

This 2012 study, published in Archives of Dermatological Research, investigates candidate gene polymorphisms associated with non-segmental vitiligo in a Russian population sample (100 patients and 100 healthy controls). A strong, statistically significant association was identified between vitiligo and the GSTP1 gene polymorphism rs1138272. The rs1138272 polymorphism causes an amino acid substitution (Ala114Val) that downregulates the activity of glutathione-S-transferase P1, a phase II detoxification enzyme. Decreased enzyme activity impairs cellular redox control and oxidative stress response, which likely contributes to vitiligo pathogenesis. Haplotype and single-SNP analyses also suggested potential disease susceptibility links with LPP, GNB3, NAT2, NOS3, DDC, and the HLA-A region.

The findings highlight the critical role of Phase II detoxication/antioxidant defense systems in vitiligo and support a multigenic model where multiple low-risk alleles cumulatively increase overall disease susceptibility.

Minashkin MM, Salnikova LE, Lomonosov KM, Korobko IV, Tatarenko AO.



FAQOther Questions

  • What's better: laser or phototherapy?

    Laser therapy is actually a type of phototherapy. Both rely on light to trigger changes in the skin, but they work differently. Phototherapy usually means a narrow-band UV (NB-U...

  • Can Ginkgo Biloba help with vitiligo?

    Ginkgo Biloba offers a promising, simple, and relatively affordable option for managing vitiligo. Known for its anti-inflammatory, immunomodulatory, and antioxidant properties, ...

  • Is it possible to stop the progression of vitiligo?

    While it's not always possible to quickly stop vitiligo progression, there are some treatments that can help slow or halt the spread of the condition in many cases: Corticostero...